| Company Name: | Coventry Health Care Inc | | Ticker Symbol: | CVH | | | WWW Address: | www.cvty.com | | CEO: | Allen F. Wise | | No. of Employees: | 15,800 | | Common Issue Type: | CS | | Business Description: | A national managed health care company based in Bethesda, Maryland operating health plans, insurance companies, network rental and workers compensation services companies.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] | |
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 22.54 | -0.09 | 22.0 | 23.13 | 22.39 | 22.76 | 22.38 | 1702933 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 3,335.9 | 148.0 | 1.95 | 2.54 | 0.00 | 15.0 | 0.0 | 24.84 - 7.97 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 22.54 | $ | | PE Ratio - LTM | 15.0 | |
| Market Capitalisation | 3,335.5 | mil |
| Latest Shares Outstanding | 148.0 | mil |
| Earnings pS (EPS) | 2.54 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 759,271 | $ |
| Effective Tax Rate | 37.0 | % |
| Float | 147.5 | mil |
| Float as % of Shares Outstanding | 98.6 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 3.6 | % |
| Pre-Tax Profit Margin | 2.9 | % |
| Assets Turnover | 1.8 | % |
| Return on Assets (ROA) | 2.7 | % |
| Return on Equity (ROE) | 6.1 | % |
| Return on Capital Invested (ROCI) | 4.2 | % |
| Current Ratio | 0.0 | |
| Leverage Ratio (Assets/Equity) | 2.3 | |
| Interest Cover | 5.5 | |
| Total Debt/Equity (Gearing Ratio) | 0.47 | |
| LT Debt/Total Capital | 32.0 | % |
| Working Capital pS | 0.00 | $ |
| Cash pS | 0.00 | $ |
| Book-Value pS | 24.34 | $ |
| Tangible Book-Value pS | 3.89 | $ |
| Cash Flow pS | 1.50 | $ |
| Free Cash Flow pS | 5.32 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.93 | |
| Price/Tangible Book Ratio | 5.79 | |
| Price/Cash Flow | 15.1 | |
| Price/Free Cash Flow | 4.2 | |
| P/E as % of Industry Group | 53.0 | % |
| P/E as % of Sector Segment | 150.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
| 
|  | | Share price performance intraday |
| 
| |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -1.9 | 98 | 17,488 | 98,983 |
| 4 Weeks | 23.76 | 18.21 | 18.70 | 20.5 | 119 | 26,653 | 533,070 |
| 13 Weeks | 24.84 | 18.18 | 22.74 | -0.9 | 93 | 24,540 | 1,570,565 |
| 26 Weeks | 24.84 | 15.89 | 18.44 | 22.2 | 99 | 23,219 | 2,948,795 |
| 52 Weeks | 24.84 | 7.97 | 10.57 | 113.2 | 156 | 25,036 | 6,283,976 |
| YTD | 24.84 | 7.97 | - | 51.5 | 125 | 26,015 | 5,853,309 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 23.11 | 22.95 | 20.61 | 20.01 | 18.16 | 1.95 | 2.11 |
|
| |
| GROWTH RATES | 5-Year Growh | R² of 5-Year Growth | 3-Year Growth |
| Revenue | 20.47 | 98.8 | 19.09 |
| Income | -4.96 | 9.5 | -20.73 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 50.18 | NA | -19.09 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | -4.11 | NA | -18.76 |
| | | CHANGES | YTD vs. Last YTD | Curr Qtr vs. Qtr 1-Yr ago | Annual vs. Last Annual |
| Revenue % | 17.9 | 16.4 | 19.7 |
| Earnings % | -54.6 | -17.4 | -39.0 |
| EPS % | -53.6 | -17.2 | -36.2 |
| EPS $ | -1.04 | -0.10 | -1.44 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| |
| |
| |
| |
| FINANCIAL STRUCTURE RATIOS |
| Financial Leverage Ratio (Assets/Equity) | 2.25 |
| Debt Ratio | 55.60 |
| Total Debt/Equity (Gearing Ratio) | 0.55 |
| LT Debt/Equity | 0.55 |
| LT Debt/Capital Invested | 35.67 |
| LT Debt/Total Liabilities | 44.28 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 0.45 |
| Current P/E Ratio - LTM | 15.00 |
| Enterprise Value (EV)/EBITDA | 0.04 |
| Enterprise Value (EV)/Free Cash Flow | 4.93 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.79 |
| Price/Book Ratio - LTM | 0.93 |
| Price/Cash Flow Ratio | 15.1 |
| Price/Free Cash Flow Ratio - LTM | 4.2 |
| P/E Ratio (1 month ago) - LTM | 12.4 |
| P/E Ratio (26 weeks ago) - LTM | 9.1 |
| P/E Ratio (52 weeks ago) - LTM | 3.4 |
| 5-Y High P/E Ratio | 25.2 |
| 5-Y Low P/E Ratio | 3.7 |
| 5-Y Average P/E Ratio | 13.6 |
| Current P/E Ratio as % of 5-Y Average P/E | 111 |
| P/E as % of Industry Group | 53.0 |
| P/E as % of Sector Segment | 150.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 13.3 |
| PER SHARE FIGURES |
| Tangible Book Value pS - LTM | 3.89 |
| Book Value pS - LTM | 24.34 |
| Capital Invested pS | 36.04 |
| Cash Flow pS - LTM | 1.50 |
| Free Cash Flow pS - LTM | 5.32 |
| Earnings pS (EPS) | 2.54 |
| | | | OPERATING RATIOS | | PROFITABILITY |
| Return on Equity (ROE) | 11.13 |
| Return on Equity (ROE) - 5YEAR AVRG. | 17.9 |
| Return on Capital Invested (ROCI) | 7.16 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 12.9 |
| Return on Assets (ROA) | 4.94 |
| Return on Assets (ROA) - 5YEAR AVRG. | 8.7 |
| EBIT Margin - LTM | 3.6 |
| EBITDA Margin - LTM | 3.6 |
| |
| |
| |
| |
| |
| |
| EFFICIENCY RATIOS |
| Revenue per Employee - LTM | 865,489 |
| Net Income per Employee - LTM | 14,017 |
| Assets/Revenue - LTM | 58.82 |
| |
|
|  





|
| |
 |  |